Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, Perera P, Machin A, Gardiner C.

J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1387-96.

PMID:
15502598
2.

Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.

Kamijima K, Murasaki M, Asai M, Higuchi T, Nakajima T, Taga C, Matsunaga H.

Psychiatry Clin Neurosci. 2004 Aug;58(4):427-33.

3.

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.

Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A.

Arch Gen Psychiatry. 2004 Nov;61(11):1153-62.

PMID:
15520363
4.

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

Emslie GJ, Wagner KD, Kutcher S, Krulewicz S, Fong R, Carpenter DJ, Lipschitz A, Machin A, Wilkinson C.

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):709-19.

PMID:
16721321
5.

Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.

Hollander E, Allen A, Steiner M, Wheadon DE, Oakes R, Burnham DB; Paroxetine OCD Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1113-21.

PMID:
14628989
6.

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT.

J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):222-9.

PMID:
11211371
7.

Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.

Stein DJ, Andersen EW, Tonnoir B, Fineberg N.

Curr Med Res Opin. 2007 Apr;23(4):701-11.

PMID:
17407626
8.

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19-29.

PMID:
12880497
9.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
10.

Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder.

Rosenberg DR, Stewart CM, Fitzgerald KD, Tawile V, Carroll E.

J Am Acad Child Adolesc Psychiatry. 1999 Sep;38(9):1180-5.

PMID:
10504818
11.
12.

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9.

PMID:
11437015
13.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982
14.

A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.

Denys D, van der Wee N, van Megen HJ, Westenberg HG.

J Clin Psychopharmacol. 2003 Dec;23(6):568-75.

PMID:
14624187
15.

A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

Denys D, van Megen HJ, van der Wee N, Westenberg HG.

J Clin Psychiatry. 2004 Jan;65(1):37-43.

PMID:
14744166
16.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
17.

Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.

Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M.

J Clin Psychiatry. 2010 Jun;71(6):784-92. doi: 10.4088/JCP.09m05911blu. Epub 2010 May 4.

PMID:
20492845
20.

Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.

Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M.

J Am Acad Child Adolesc Psychiatry. 2001 Oct;40(10):1175-81.

PMID:
11589530

Supplemental Content

Support Center